Financials
Financial year 2025
Apotheek Delendeker from Leuven, company number BE0445165563, closed financial year 2025 with a result of € 20,425 after tax. For that financial year Apotheek Delendeker recorded a gross margin of € 35,699 and equity of € 229,787. Compared with financial year 2024, the result moved from € -2,023 to € 20,425. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2026.
€ 229,787
▲ 10% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 20,425
▲ still € 2,023 loss in 2024
Profit after tax over the fiscal year.
€ 69,451
▲ 9% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 124,432.
People and assets in 2025
0
Average over the fiscal year, from the social balance sheet.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 23,055
▼ 8% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 8,969
▲ € 8,045 vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 96,416 | € 95,274 | € 24,444 | € 35,699 | ▲ 46% |
| Profit after taxes | € 63,389 | € 61,037 | € -2,023 | € 20,425 | ▲ € 22,448 |
| Equity | € 285,349 | € 211,385 | € 209,362 | € 229,787 | ▲ 10% |
| Total debts | € 36,214 | € 37,420 | € 25,886 | € 32,024 | ▲ 24% |
| Cash | € 136,928 | € 73,476 | € 63,542 | € 69,451 | ▲ 9% |
| Land & buildings | € 5,560 | € 16,962 | € 12,291 | € 8,288 | ▼ 33% |
| Retained profit | € 179,994 | € 106,031 | € 104,007 | € 124,432 | ▲ 20% |
| Dividend | € 50,000 | € 135,000 | € 0 | € 0 | |
| Bank debt | € 11,730 | € 11,797 | € 0 | € 0 | |
| Balance sheet total | € 321,563 | € 248,805 | € 235,248 | € 261,811 | ▲ 11% |
Key figures of Apotheek Delendeker, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Apotheek Delendeker?
What happened at Apotheek Delendeker in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 20,425. filed late Source: NBB ↗
- New establishment in Leuven. KBO
- Start of the company according to the CBE. KBO
In short
From € 63,389 profit in 2022 to € 20,425 profit in 2025.
Paid € 51,179 in corporate taxes since 2022.
Best year ever: 2022, with € 63,389 profit.
Paid out € 185,000 in dividends to the owners in total.
Management
The stake of DEKERK, ADL Pharma comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Apotheek DelendekerBehind Apotheek Delendeker is ADL Pharma BV. The shares are held by DEKERK (100%) and ADL Pharma (100%).
Directors
According to the 2025 annual accounts
Director · represented by Anneleen Delendeker
Shareholders
100%
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Pakenstraat 5
3001 Leuven
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0445.165.563
- VAT number
- BE 0445.165.563
- Registered office
- Pakenstraat 5, 3001 Leuven
- Names & denominations
- Apotheek Delendeker
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 13 September 1991
- Peppol
- Active · Active since 30 Jan 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers